Publication & Citation Trends
Publications
17 total
Does time from diagnosis to treatment affect the prognosis of patients with newly diagnosed acute myeloid leukemia? PDF
Cited by 135
OpenAlex
Time from Diagnosis to Treatment Does Not Affect Outcome in Intensively Treated Patients with Newly Diagnosed Acute Myeloid Leukemia. OA
Cited by 19
Semantic Scholar
Multiple Myeloma Treatment in Real-world Clinical Practice: Results of a Prospective, Multinational, Noninterventional Study PDF
Cited by 89
OpenAlex
Intermediate-dose cytarabine plus mitoxantrone versus standard-dose cytarabine plus daunorubicin for acute myeloid leukemia in elderly patients OA
Cited by 30
Semantic Scholar
Multiple Myeloma Treatment in Real‐world Clinical Practice: Results of a Prospective, Multinational, Noninterventional Study OA
Cited by 70
Semantic Scholar
Real World Data on Decitabine Treatment in 296 Patients with Acute Myeloid Leukemia: Outcome and Impact of TP53 Mutations
Cited by 0
Semantic Scholar
The Addition of Sorafenib to Standard AML Treatment Results in a Substantial Reduction in Relapse Risk and Improved Survival. Updated Results from Long-Term Follow-up of the Randomized-Controlled Soraml Trial
Cited by 25
Semantic Scholar
Addition of sorafenib versus placebo to standard therapy in patients aged 60 years or younger with newly diagnosed acute myeloid leukaemia (SORAML): a multicentre, phase 2, randomised controlled trial PDF
Cited by 397
OpenAlex
Research Topics
Acute Myeloid Leukemia Research
(8)
Multiple Myeloma Research and Treatments
(3)
Platelet Disorders and Treatments
(3)
Myeloproliferative Neoplasms: Diagnosis and Treatment
(3)
Protein Degradation and Inhibitors
(3)
Affiliations
Agaplesion Diakonieklinikum Rotenburg
University of Lübeck